news Non-invasive optical method could provide insight into brain diseases 19 July 2021 | By Anna Begley (Drug Target Review) A non-invasive, label-free optical method can produce high-resolution imaging of cellular brain diseases in vivo.
news Computational modelling reveals SARS-CoV-2 mutation ‘hotspots’ 20 May 2021 | By Victoria Rees (Drug Target Review) A new modelling method could be used as a surveillance tool to monitor emerging infectious SARS-CoV-2 variants, scientists say.
news D614G Spike mutation makes SARS-CoV-2 up to eight times more infectious 18 February 2021 | By Victoria Rees (Drug Target Review) A study has shown the D614G mutation in the Spike protein of SARS-CoV-2 makes the coronavirus more transmissible than the original virus from China.
news CRISPR RNA-targeted genetic screen could be used for COVID-19 therapy 18 March 2020 | By Hannah Balfour (Drug Target Review) A new Cas13 RNA screen has been used to establish guide RNAs for the COVID-19 coronavirus and human RNA segments which could be used in vaccines, therapeutics and diagnostics.
news Study reveals antioxidant role in spread of lung cancer 1 July 2019 | By Victoria Rees (Drug Target Review) Researchers have discovered that lung cancer cells metastasise using antioxidants, informing potential future therapies.
news Bacterial outer membranes may be key to new antibiotics 22 July 2018 | By Drug Target Review The outer membrane surrounding the cell wall of bacteria may be a key target for approaches to a new form of antibacterial drugs...
news Alpha-synuclein clumps promote Parkinson’s progression 14 June 2018 | By Dr Zara Kassam (Drug Target Review) Detailed brain cell analysis has helped researchers uncover new mechanisms thought to underlie Parkinson's disease...